BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36252994)

  • 1. Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease.
    Nissen SE; Wolski K; Cho L; Nicholls SJ; Kastelein J; Leitersdorf E; Landmesser U; Blaha M; Lincoff AM; Morishita R; Tsimikas S; Liu J; Manning B; Kozlovski P; Lesogor A; Thuren T; Shibasaki T; Matei F; Silveira FS; Meunch A; Bada A; Vijan V; Bruun NE; Nordestgaard BG;
    Open Heart; 2022 Oct; 9(2):. PubMed ID: 36252994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
    Hedegaard BS; Bork CS; Kaltoft M; Klausen IC; Schmidt EB; Kamstrup PR; Langsted A; Nordestgaard BG
    J Am Coll Cardiol; 2022 Nov; 80(21):1998-2010. PubMed ID: 36396201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein (a) concentration as a risk factor for ischaemic stroke and its subtypes.
    Lackova A; Gdovinova Z; Kozarova M; Koreň D; Lacko M
    Neurol Neurochir Pol; 2024; 58(3):316-322. PubMed ID: 38767133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipoprotein(a) measured in the routine clinical care is associated to atherosclerotic cardiovascular disease during a 14-year follow-up.
    Littmann K; Hagström E; Häbel H; Bottai M; Eriksson M; Parini P; Brinck J
    Eur J Prev Cardiol; 2022 Feb; 28(18):2038-2047. PubMed ID: 34343284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of First and Total Recurrent Atherosclerotic Cardiovascular Disease Events to Increased Lipoprotein(a) Levels Among Statin Treated Adults With Cardiovascular Disease.
    Wong ND; Zhao Y; Sung J; Browne A
    Am J Cardiol; 2021 Apr; 145():12-17. PubMed ID: 33454339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
    Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
    J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the Potential Association Between Lipoprotein(a) and Atherosclerosis (from the Mediators of Atherosclerosis Among South Asians Living in America Cohort).
    Huffman MD; Kandula NR; Baldridge AS; Tsai MY; Prabhakaran D; Kanaya AM
    Am J Cardiol; 2019 Mar; 123(6):919-921. PubMed ID: 30626499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment.
    Stiekema LCA; Stroes ESG; Verweij SL; Kassahun H; Chen L; Wasserman SM; Sabatine MS; Mani V; Fayad ZA
    Eur Heart J; 2019 Sep; 40(33):2775-2781. PubMed ID: 30561610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a): A Concealed Precursor of Increased Cardiovascular Risk? A Real-World Regional Lipid Clinic Experience.
    Anastasiou G; Sakka E; Blathra E; Kalivi A; Elisaf M; Liamis G; Liberopoulos E
    Arch Med Res; 2021 May; 52(4):397-404. PubMed ID: 33380360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank.
    Patel AP; Wang (汪敏先) M; Pirruccello JP; Ellinor PT; Ng K; Kathiresan S; Khera AV
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):465-474. PubMed ID: 33115266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Coronary Plaque With Low-Density Lipoprotein Cholesterol Levels and Rates of Cardiovascular Disease Events Among Symptomatic Adults.
    Mortensen MB; Caínzos-Achirica M; Steffensen FH; Bøtker HE; Jensen JM; Sand NPR; Maeng M; Bruun JM; Blaha MJ; Sørensen HT; Pareek M; Nasir K; Nørgaard BL
    JAMA Netw Open; 2022 Feb; 5(2):e2148139. PubMed ID: 35147685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood.
    Raitakari O; Kartiosuo N; Pahkala K; Hutri-Kähönen N; Bazzano LA; Chen W; Urbina EM; Jacobs DR; Sinaiko A; Steinberger J; Burns T; Daniels SR; Venn A; Woo JG; Dwyer T; Juonala M; Viikari J
    Circulation; 2023 Jan; 147(1):23-31. PubMed ID: 36440577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort.
    Brandt EJ; Mani A; Spatz ES; Desai NR; Nasir K
    J Clin Lipidol; 2020; 14(5):695-706.e4. PubMed ID: 32739333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States.
    Fonseca AF; Byrne H; Laguna A; Itani T; Studer R; Heo J; Dillon A; Ferber P; Costa-Scharplatz M
    J Manag Care Spec Pharm; 2023 May; 29(5):519-529. PubMed ID: 37121256
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies.
    Alhomoud IS; Talasaz A; Mehta A; Kelly MS; Sisson EM; Bucheit JD; Brown R; Dixon DL
    Pharmacotherapy; 2023 Oct; 43(10):1051-1063. PubMed ID: 37464942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease.
    Verweij SL; de Ronde MWJ; Verbeek R; Boekholdt SM; Planken RN; Stroes ESG; Pinto-Sietsma SJ
    J Clin Lipidol; 2018; 12(3):597-603.e1. PubMed ID: 29550494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) Testing Patterns in a Large Health System.
    Kelsey M; Page C; Alhanti B; Rhodes SL; Kent ST; Peterson E; Pagidipati N
    Am J Cardiol; 2021 Aug; 153():43-50. PubMed ID: 34210501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) and Increased Cardiovascular Risk in Women.
    Costello BT; Silverman ER; Doukky R; Braun LT; Aggarwal NT; Deng Y; Li Y; Lundberg G; Williams KA; Volgman AS
    Clin Cardiol; 2016 Feb; 39(2):96-102. PubMed ID: 26880352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent Relationship of Lipoprotein(a) and Carotid Atherosclerosis With Long-Term Risk of Cardiovascular Disease.
    Qi Y; Duan Y; Deng Q; Yang N; Sun J; Li J; Hu P; Liu J; Liu J
    J Am Heart Assoc; 2024 May; 13(9):e033488. PubMed ID: 38639362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.